KT&G EBIT per Share
The EBIT per Share of KT&G (033780.KS) as of Aug 14, 2026 is 11,537.60 KRW. In the previous year, EBIT per Share was 10,142.26 KRW — a change of 13.76% (higher).
Get this data via API
Financial Data API
EBIT per Share
11,537.60KRW
YoY
13.76%
Last updated:
EBIT per Share of KT&G is 2026 11,537.60 KRW. EBIT per Share of KT&G was 2025 10,142.26 KRW. It decreases by 13.76% higher compared to the previous year.
Access this data via the Eulerpool API
KT&G Stock analysis
What does KT&G do? KT&G Corp is a South Korean company that was originally established as a state monopoly for tobacco products. The abbreviation KT&G stands for Korean Tobacco & Ginseng Society. Today, the company operates in various business sectors and is headquartered in Daejeon, South Korea.
History:
KT&G was founded in 1899 when Korea was still under Japanese occupation. Originally, the company was named "Chosun Tobacco Monopoly Corporation" and produced tobacco for the Korean market. After World War II and Korea's independence, the company was renamed "Korean Tobacco & Ginseng Society" and the monopoly on tobacco production and sales continued.
It was not until the 1980s, under more liberal governments, that the tobacco monopoly was broken, increasing the company's competitiveness. In 1994, KT&G was converted into a joint-stock company and in 2002, the company went public. Today, KT&G is one of the leading companies in Korean tobacco and ginseng products with subsidiaries and business sectors both domestically and internationally.
Business Model:
KT&G is engaged in various business sectors. Its core business fields include tobacco products, ginseng products, biotechnology, pharmaceuticals, and dietary supplements. Additionally, the company has various joint ventures and subsidiaries in Asia, Europe, and North America.
Tobacco Products:
KT&G is the largest tobacco manufacturer in Korea and exports its products to over 50 countries worldwide. The company is known for its brands "Esse," "The One," "Raison," and "Timeless."
KT&G produces its products in various forms, including cigarettes, cigars, loose tobacco, and pipe tobacco. The company places great importance on research and development to produce innovative products with low levels of harmful substances.
Ginseng Products:
KT&G has also specialized in the production and sale of ginseng products. Ginseng is an Asian plant known for its health-promoting properties and versatile use in traditional Korean medicine.
KT&G produces ginseng extracts, capsules, and beverages, distributing them both domestically and internationally. The brand "Cheong-Kwan-Jang" is synonymous with high-quality ginseng products that are highly valued in Korea and worldwide.
Biotechnology and Pharmaceuticals:
KT&G also operates in the field of biotechnology and pharmaceuticals. The company has research and development programs for cancer treatments, vascular diseases, and cosmetic products.
Dietary Supplements:
Dietary supplements are another major business field for KT&G. The company produces vitamin and mineral supplements, herbal extracts, and other dietary supplements aimed at promoting health and well-being.
Subsidiaries and Joint Ventures:
KT&G has various subsidiaries and joint ventures in Asia, Europe, and North America. These include the "KT&G Sangsangmadang" brand lifestyle culture centers, the "KT&G Towers" skyscraper in Seoul, and the "KT&G Life & Science Center" in Daejeon.
Conclusion:
KT&G has evolved from a state tobacco monopoly into a diversified multinational corporation operating in various business sectors, including tobacco products, ginseng products, biotechnology, pharmaceuticals, and dietary supplements. KT&G is known in Korea and around the world for its innovative products and commitment to improving the health and well-being of its customers. KT&G is one of the most popular companies on Eulerpool.
Frequently Asked Questions about KT&G stock
EBIT per Share of KT&G is 11,537.60 KRW in 2026.
EBIT per Share of KT&G changed from 10,142.26 KRW to 11,537.60 KRW, representing a 13.76% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share KT&G since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — KT&G
All Key Metrics — KT&G
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth